JenniferSGuimbellotMD

PubMed

• Pilot and feasibility study of dietary composition with elexacaftor-tezacaftor-ivacaftor concentrations in people with cystic fibrosis.
  Natalie R Rose, Julianna Bailey, Justin D Anderson, Ashritha R Chalamalla, Kevin J Ryan
  Pharmacotherapy. 2024-12-23
• Literary evidence of the impact of nonbiological risk factors on CRMS/CFSPID: A scoping review.
  Natalie R Rose, S Garrison Dabbs, Emma C O'Hagan, Jennifer S Guimbellot
  Pediatric Pulmonology. 2024-12-01
• Evaluating the effects of ivacaftor exposure onsmall colony variant development and antibiotic tolerance.
  Gretchen E Bollar, Kendall M Shaffer, Johnathan D Keith, Ashley M Oden, Alexander E Dowell
  JAC-Antimicrobial Resistance. 2024-12-01

Journal Articles

• Sensitivity of ivacaftor to drug-drug interactions with rifampin, a cytochrome P450 3A4 inducer  
  Guimbellot JS, Acosta E, Rowe SM, Pediatr Pulmonol., 1/1/2018
• Toward Inclusive Therapy with CFTR Modulators: Progress and Challenges  
  Guimbellot JS, Sharma J, Rowe SM, Pediatr Pulmonol., 1/1/2017
• Novel measures of CFTR-dependent fluid transport in a three-dimensional nasal epithelial model  
  Guimbellot JS, Aban I, Leach JM, Chaudry IG, Quinney N, Chua M, Jaspers I, Gentzsch M, JCI Insight., 1/1/2017
• EWS/FLI function varies in different cellular backgrounds  
  Zwerner JP, Guimbellot J, May WA., Exp Cell Res, 1/1./2003
• Efficient intracellular processing of the endogenous cystic fibrosis transmembrane conductance regulator in epithelial cell lines  
  Varga K, Jurkuvenaite A, Wakefield J, Hong JS, Guimbellot JS, Venglarik CJ, Niraj A, Mazur M, Sorscher EJ, Collawn JF, Bebok Z., J Biol Chem, 1/21/2004
• Role of Oxygen in Cystic Fibrosis Transmembrane Conductance Regulator Expression and Function  
  Guimbellot JS, Fortenberry JA, Siegal GP, Moore B, Wen H, Venglarik C, Chen YF, Oparil S, Sorscher EJ, Hong JS, Am J Respir Cell Mol Biol., 1/12/2008
• Correlation of microRNA levels during hypoxia with predicted target mRNAs through genome-wide microarray analysis  
  Guimbellot JS, Erickson SW, Mehta T, Wen H, Page GP, Sorscher EJ, Hong JS., BMC Med Genomics., 1/25/2009
• Effectiveness of ivacaftor in non-G551D gating mutations  
  Guimbellot JS*, Solomon GM*, Baines A, Heltshe SL, VanDalfsen J, Joseloff E, Sagel S, Rowe SM., J Cyst Fibros, 1/20/2018
• Potential pathogenicity of Inquilinus limosus in a pediatric patient with cystic fibrosis  
  Poore TS, Virella-Lowell I, Guimbellot JS., Pediatr Pulmonol., 1/23/2018
• Join now to see all

Abstracts/Posters

• Lung on a Chip: The Functional Characterization of Mucociliary Clearance Using Micro Optical Coherence Tomography (�OCT).
  Mackay S, Gordon D, Liu Z, Fortinberry HK, Rosano J, PrabhakarPandian B, Rowe SM, Guimbellot JS, Pulmonary and Critical Care Update, Birmingham, AL, 1/1/2017
• Sodium butyrate mediated enhancement of F508 CFTR expression involves altered protein degradation.
  Guimbellot JS, Varga K, Collawn JF, Sorscher EJ and Bebok Z, Eastern-Atlantic Student Research Forum, Miami, FL, 1/1/2004
• Evidence for acquired defects in CFTR transcription and function caused by hypoxia.
  Guimbellot JS., Moore, B., Wen, H., Venglarik, C., Sorscher, E.J., and Hong, J.S., European Respiratory Society Fourth Lung Science Conference, Taormina, Sicily, Italy, 1/23/2006
• DNA methylation and histone acetylation contribute to transcriptional regulation of CFTR in response to hypoxia.
  Guimbellot JS, Fortenberry JA, Siegal G, Chen Y-F, Oparil S, Sorscher EJ, and Hong JS., North American Cystic Fibrosis Conference, Pediatr Pulmonol Suppl., Baltimore, MD, 1/20/2005
• Effect of ozone on CFTR and HIF expression and function.
  Guimbellot JS,Fortenberry JA, Rowe S, Ballinger C, Postlethwait E, Sorscher EJ., North American Cystic Fibrosis Conference, Pediatr Pulmonol Suppl., Denver, CO, 1/2./2006
• Correlation of microRNA levels and predicted target mRNAs in hypoxia.
  Guimbellot JS, Erickson SW, Wen H, Page GP, Sorscher EJ, Hong JS, American Society of Clinical Investigation /American Physician Scientists Association Annual Meeting, North American Cystic Fibrosis Conference, Pediatr Pulmonol Suppl., Anaheim, CA, 2007; Chicago, IL, 2007, 1/3./2007
• A mouse model of cystic fibrosis has a different protein composition of the pulmonary epithelial lining fluid compared to wild type counterparts.
  Guimbellot JS, Asmellash SG, Bowersock GJ, Ballinger CA, Fortenberry J, Ramos H, Qi RJ, Shambaugh JD, Postlethwait EM, Sorscher EJ, Mobley J., North American Cystic Fibrosis Conference, Pediatr Pulmonol Suppl., Orlando, FL, 1/23/2008
• Role of PRKRA in the development of isolated microtia
  Guimbellot JS, Pyle LC, Spencer EG, Johnson KR, Callens T, Vasconez L, Vasconez H, Engels B, Fix J, Robin N, Messiaen L., American Society of Human Genetics, Philadelphia, PA, 1/11/2008
• Risk factors for pneumothorax in VLBW infants
  Guimbellot JS and Bateman DB, Children�s Hospital of New York Presbyterian Research Day, New York, NY, 1/16/2011
• Primary Ciliary Dyskinesia and Cri du Chat Syndrome: A Genetic Connection
  Guimbellot JS, Shapiro AJ, Weck KE, Chao K, Zariwala MA, Rosenfeld M, Maranda B, Knowles MR, Leigh MW, American Thoracic Society International Meeting, San Diego, CA, 1/16/2014
• Increase in Pseudomonas Infection in Children Undergoing Tracheotomy.
  Guimbellot JS, Reilly CA, Kerr A, Gilligan PH, Muhlebach MS, Esther CR, American Thoracic Society International Meeting, San Diego, CA, 1/16/2014
• Novel measures of CFTR-dependent fluid transport in nasospheroids, a three-dimensional primary ex vivo nasal epithelial model.
  Guimbellot JS, Aban I, Leach JM, Chaudry IG, Quinney NO, Boyles SE, Chua M, Jaspers I, Gentzsch M., Cystic Fibrosis Foundation Research Conference, North American Cystic Fibrosis Conference, Stevenson, WA, 2017; Indianapolis, IN, 2017, 1/1./2017
• Microfluidics airway model measures mucociliary transport apparatus.
  Mackay S, Liu Z, Fortinberry HK, Solomon GM, Gordon D, Garson C, Haithcock D, Ramsey D, Tearney G, Pant K, Pandian P, Rowe SM, Guimbellot JS., North American Cystic Fibrosis Conference, Indianapolis, IN, 1/1./2017
• Sweat gland cultures for the study of cystic fibrosis.
  Guimbellot JS, Mackay S, Liu Z, Joseph D, Bebok Z, Rowe SM, McNicholas-Bevensee CM., North American Cystic Fibrosis Conference, Indianapolis, IN, 1/1./2017
• Join now to see all

Lectures

• Novel approaches to predict CFTR modulator efficacy in cystic fibrosis 
  1/1/2018
• Cystic Fibrosis Modulators 
  1/1/2017
• Novel models for predicting CFTR modulator efficacy in cystic fibrosis 
  1/1/2017
• Novel models for predicting CFTR modulator efficacy in cystic fibrosis. 
  Birmingham, AL - 1/1/2017
• Cystic Fibrosis 
  1/1/2016
• Mechanics of breathing 
  1/1/2015
• Disorders of the Chest Wall 
  1/1/2014
• Pulmonary considerations in Children with Neuromuscular diseases 
  1/1/2013
• Environmental and Food Allergies in Children 
  1/1/2012
• Sleep Disordered Breathing 
  1/1/2011
• Care of the NICU graduate 
  1/1/2011
• Role of oxygen sensing in CFTR expression and function 
  St. Louis, MO, 2004; University of Alabama at Birmingham, 2004; Galveston, Texas, 2005 - 1/1/2005
• Epidemiology of tracheostomy Infections. 
  University of North Carolina, Chapel Hill, NC. - 1/14/2013
• Influence of bacteria on F508del CFTR correction by VX-809. 
  Atlanta, GA - 1/10/2014
• Join now to see all